Guangdong Jiaying Pharmaceutical Co., Ltd
Symbool: 002198.SZ
SHZ
6.73
CNYMarktprijs vandaag
121.8232
Koers/Winst Verhouding
10.9641
Koers/Winst Groei Verhouding
3.42B
MRK Kapitalisatie
- 0.00%
DIV Rendement
Guangdong Jiaying Pharmaceutical Co., Ltd (002198-SZ) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1231.73 | 334 | 234.1 | 239.4 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 660.9 | 200.5 | 50.3 | 0 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 657.68 | 154 | 240.6 | 175.7 | ||||||||||||||||||||
balance-sheet.row.inventory | 347.58 | 84.6 | 82.3 | 73.4 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 5.96 | 1.1 | 0.4 | 1.2 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 2267.86 | 580.2 | 557.4 | 489.7 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 769.11 | 190.4 | 203.7 | 224.2 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 191.46 | 47.2 | 52.4 | 58.3 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 191.46 | 47.2 | 52.4 | 58.3 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | -134.09 | 27.1 | -20.9 | 30.6 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 8.72 | 2.2 | 2.2 | 4.6 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 240.92 | 0.5 | 51.8 | 0 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1076.11 | 267.4 | 289.2 | 317.7 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 3343.97 | 847.6 | 846.7 | 807.3 | ||||||||||||||||||||
balance-sheet.row.account-payables | 42.13 | 9.2 | 19 | 14.1 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | -2.03 | 0 | 5.8 | 31.1 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 28.03 | 7.5 | 17.2 | 12 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||||||||||||||||
Deferred Revenue Non Current | 1.72 | 0.4 | 0.5 | 0.2 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 139.12 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 118.62 | 40.2 | 47.1 | 5.7 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 140.84 | 35.2 | 35.3 | 34.9 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-liab | 315.92 | 84.6 | 118.2 | 122.9 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 54.45 | 27.2 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 2030.04 | 507.5 | 507.5 | 507.5 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 398.09 | 104.6 | 70.3 | 26.3 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 174.76 | 0 | 27.2 | 27.2 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 370.71 | 123.7 | 123.4 | 123.4 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3028.05 | 763 | 728.4 | 684.5 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 3343.97 | 847.6 | 846.7 | 807.3 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 3028.05 | 763 | 728.4 | 684.5 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 3343.97 | - | - | - | ||||||||||||||||||||
Total Investments | 105.91 | 27.1 | 29.4 | 30.6 | ||||||||||||||||||||
balance-sheet.row.total-debt | 5.87 | 0 | 5.8 | 31.1 | ||||||||||||||||||||
balance-sheet.row.net-debt | -564.95 | -133.5 | -178.1 | -208.3 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 27.32 | 43.9 | 1.5 | 19.8 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 18.01 | 25.9 | 28.4 | 28.2 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 2.4 | 1 | -0.6 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -2.4 | -1 | 0.6 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 116.01 | -48.4 | -4.8 | 38.8 | |||||||||||||||||||
cash-flows.row.account-receivables | 118.37 | -86.5 | 9.6 | 9 | |||||||||||||||||||
cash-flows.row.inventory | -2.36 | -8.4 | -0.8 | 2.5 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 44.1 | -14.7 | 27.9 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 2.4 | 1 | -0.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | -48.06 | 5.7 | 26.7 | 10 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 113.28 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -12.26 | -2.7 | -2.3 | -11.7 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 141.97 | 0.1 | 0 | 0 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -0.1 | 0 | 0 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -126.83 | 1.6 | 32.5 | 18.5 | |||||||||||||||||||
cash-flows.row.other-investing-activites | -180 | -49.9 | 25.1 | -25 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -176.93 | -51 | 55.2 | -18.2 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -31.1 | -15 | -135 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -0.5 | -1 | -3.8 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | 0 | 31.1 | 55 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -31.6 | 15.1 | -83.8 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | -64.89 | -55.4 | 122.1 | -5.1 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 567.95 | 183.9 | 239.3 | 117.2 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 632.85 | 239.3 | 117.2 | 122.3 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 113.28 | 27.2 | 51.8 | 96.9 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -12.26 | -2.7 | -2.3 | -11.7 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 101.02 | 24.4 | 49.5 | 85.2 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 499.15 | 533.2 | 659.2 | 574.7 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 184.54 | 185.5 | 228.5 | 141.9 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 314.61 | 347.7 | 430.7 | 432.8 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 10.47 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 13.37 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 219.49 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | -1.19 | -1.1 | 40.7 | 46.3 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 285.61 | 310.4 | 376 | 403.2 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 470.15 | 495.9 | 604.5 | 545.1 | ||||||||||||||||||||
income-statement-row.row.interest-income | 2.17 | 2.1 | 2.3 | 2.6 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.5 | 1 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 219.49 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0.14 | 2.1 | -2.8 | -27.8 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -1.19 | -1.1 | 40.7 | 46.3 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0.14 | 2.1 | -2.8 | -27.8 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 0.5 | 1 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 8.91 | 24.2 | 26.6 | 28.4 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 30.17 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 33.65 | 40.5 | 53.9 | 33.6 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 32.46 | 39.4 | 51.1 | 5.8 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 5.15 | 5.1 | 7.2 | 4.3 | ||||||||||||||||||||
income-statement-row.row.net-income | 27.32 | 34.3 | 43.9 | 1.5 |
Vaak gestelde vragen
Wat is Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) totale activa?
Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) totale activa is 847563113.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is 250417163.000.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.630.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.055.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.067.
Wat is Guangdong Jiaying Pharmaceutical Co., Ltd (002198.SZ) nettowinst (netto-inkomen)?
De nettowinst is 34320234.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 0.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 310409681.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 118503980.000.